Pages that link to "Q33544588"
Jump to navigation
Jump to search
The following pages link to Expanded activity and utility of the new fluoroquinolones: a review (Q33544588):
Displaying 50 items.
- Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitis (Q31096601) (← links)
- Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance (Q33614494) (← links)
- Gatifloxacin (Q33768758) (← links)
- Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections: a review of microbiologic and pharmacokinetic-pharmacodynamic characteristics (Q33871466) (← links)
- Drug utilization reviews of oral quinolone, cephalosporin, and macrolide use in nonacute care: a systematic review (Q33965247) (← links)
- Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains (Q33980337) (← links)
- Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections (Q33981431) (← links)
- Drug interactions with clinafloxacin (Q33982922) (← links)
- The safety profile of the fluoroquinolones. (Q34005865) (← links)
- Clinical pharmacology of gatifloxacin, a new fluoroquinolone (Q34030783) (← links)
- A review of clinical trials with fluoroquinolones with an emphasis on new agents (Q34074724) (← links)
- Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections. (Q34141064) (← links)
- Evaluation of the clinical microbiology profile of moxifloxacin (Q34183540) (← links)
- Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials (Q34235318) (← links)
- A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections (Q34248416) (← links)
- Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent (Q34372538) (← links)
- Investigational antimicrobial agents of 2013. (Q34375204) (← links)
- Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics (Q34437719) (← links)
- Gatifloxacin: a review of its use in the management of bacterial infections (Q34492637) (← links)
- Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center (Q34520874) (← links)
- Prulifloxacin: a new antibacterial fluoroquinolone (Q34564526) (← links)
- Binding interactions of pefloxacin mesylate with bovine lactoferrin and human serum albumin (Q34657806) (← links)
- Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children (Q34756483) (← links)
- Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections (Q34789110) (← links)
- Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum (Q34882995) (← links)
- The effect of ciprofloxacin on sperm DNA damage, fertility potential and early embryonic development in NMRI mice (Q35034719) (← links)
- Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects (Q35102747) (← links)
- Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections (Q35164756) (← links)
- Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin (Q35374935) (← links)
- The fluoroquinolones: how long will their utility last? (Q35733987) (← links)
- Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals (Q36254302) (← links)
- New findings on the structure-phototoxicity relationship and photostability of fluoroquinolones with various substituents at position 1. (Q36489661) (← links)
- Acute bacterial rhinosinusitis: a review of U.S. treatment guidelines (Q36584323) (← links)
- Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones (Q37191156) (← links)
- Astrocytes: adaptive responses to low doses of neurotoxins (Q37196495) (← links)
- Selective drug delivery to bone using acidic oligopeptides (Q37329087) (← links)
- Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections (Q37577369) (← links)
- Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012 (Q37643589) (← links)
- Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects (Q37710505) (← links)
- Analytical methods for determination of new fluoroquinolones in biological matrices and pharmaceutical formulations by liquid chromatography: a review (Q37982661) (← links)
- State-of-the-art applications of cyclodextrins as functional monomers in molecular imprinting techniques: a review (Q38871019) (← links)
- Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin (Q39730788) (← links)
- Antibiotic Therapy for Acute Watery Diarrhea and Dysentery (Q40060459) (← links)
- Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function (Q40392507) (← links)
- A study on the toxicity of intravitreal levofloxacin in rabbits (Q40630867) (← links)
- Effects of ciprofloxacin-containing antimicrobial scaffolds on dental pulp stem cell viability-In vitro studies (Q40870098) (← links)
- Aqueous penetration of orally and topically administered moxifloxacin (Q41369432) (← links)
- Biphasic response of ciprofloxacin in human fibroblast cell cultures (Q41836716) (← links)
- Influence of type and neutralisation capacity of antacids on dissolution rate of ciprofloxacin and moxifloxacin from tablets (Q42379710) (← links)
- Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells. (Q42481542) (← links)